Efficient purification of mouse anti-FGF receptor IgM monoclonal antibody by magnetic beads

Hybridoma

Volumn 17, Issue 2, 1998, Pages 199-207

  Quitadamo, Ian J ^a   Schelling, Margaret E ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR; IMMUNOGLOBULIN M; MONOCLONAL ANTIBODY;

ANGIOGENESIS; ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY TITER; ANTIGEN PURIFICATION; ARTICLE; CELL TYPE; CYTOTOXICITY; GENE TARGETING; IMMUNOAFFINITY CHROMATOGRAPHY; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN PURIFICATION; RECEPTOR GENE;

ANIMALIA; BOVINAE; MURINAE;

EID: 0031805733     PISSN: 0272457X     EISSN: None     Source Type: Journal    
DOI: 10.1089/hyb.1998.17.199     Document Type: Article

References (40)

1. Decken K, Schmitz D-BJ, Rohde D, Nakamura S, Ebert T, and Ackermann, R: Monoclonal antibody Due ABC 3 directed against transitional cell carcinoma. I. Production, specificity analysis, and preliminary characterization of the antigen. J Urol 1992;147(1):235-241.
2. Lehmann HP, Zwicky C, Waibel R, and Stahel RA: Tumor-antigen-specific humoral immune response of animals to anti-idiotypic antibodies and comparative serological analysis of patients with small-cell lung carcinoma. Int J Cancer 1992;50:86-92.
3. Livingston P, Zhang S, Adluri S, Yao TJ, Graeber L, Ragupathi G, Helling F, and Fleisher M: Tumor cell reactivity mediated by IgM antibodies in sera from melanoma patients vaccinated with GM2 ganglioside covalently linked to KLH is increased by IgG antibodies. Cancer Immunol Immunother 1997;43:324-330.
4. Ballou B, Fisher GW, Waggoner AS, Farkas DL, Reiland JM, Jaffe R, Mujumdar RB, Mujumdar SR, and Hakala TR: Tumor labeling in vivo using cyanine-conjugated monoclonal antibodies. Cancer Immunol Immunother 1995;41:257-263.
5. Quadri SM, Malik AB, Tang XZ, Patenia R, Freedman RS, and Vriesendorp HM: Preclinical analysis of intraperitoneal administration of 111In-labeled human tumor reactive monoclonal IgM AC6C3-2B12. Cancer Res 1995;55(23 Suppl):5736s-5742s.
6. Ballou B, Jaffe R, Persiani S, Shen WC, Langone JJ, Sands H, Reilandu JM, Curley J, and Hakala TR: Tissue localization of methotrexate-monoclonal-IgM immunoconjugates: Anti-SSEA-1 and MOPC 104E in mouse teratocarcinomas and normal tissues. Cancer Immunol Immunother 1992;35:251-256.
7. Migliorati CA, Ranken R, Kaplan M, and Silverman S, Jr: Use of monoclonal antibody 17.13 in the diagnosis of human oral squamous cell carcinoma. J Oral Pathol Med 1990;19:414-418.
8. Gorogh T, Lippert BM, Paulsen JI, Folz BJ, Gottschlich S, Sabzeghabari M, and Werner JA: [Monoclonal antibodies against squamous epithelial carcinomas of the upper aerodigestive tract]. Laryngo Rhino Otologie 1996;75:677-681.
9. Quadri SM, Malik AB, Chu HB, Freedman RS, and Vriesendorp HM: Intraperitoneal indium-111- and yttrium-90-labeled human IgM (AC6C3-2B12) in nude mice bearing peritoneal carcinomatosis. J Nucl Med 1996;37:1545-1551.
10. Jinno H, Ueda M, Enomoto K, Ikeda T, Kyriakos P, and Kitajima M: Effectiveness of an adriamycin immunoconjugate that recognizes the C-erbB-2 product on breast cancer cell lines. Surg Today 1996;26:501-507.
11. Aboud P-E, Hurwitz E, Bellot F, Schlessinger J, and Sela M: Inhibition of human tumor growth in nude mice by a conjugate of doxorubicin with monoclonal antibodies to epidermal growth factor receptor. Proc Natl Acad Sci USA 1989;86: 3778-3781.
12. Tokuda Y, Ohnishi Y, Shimamura K, Iwasawa M, Yoshimura M, Ueyama Y, Tamaoki N, Tajima T, and Mitomi T: In vitro and in vivo anti-tumour effects of a humanised monoclonal antibody against c-erbB-2 product. Br J Cancer 1996;73:1362-1365.
13. Tosi E, Valota O, Canevari S, Adobati E, Casalini P, Perez P, and Colnaghi MI: Anti-idiotypic response to anti-growth factor receptor monoclonal antibodies. Eur J Cancer 1996;32A:498-505.
14. Folkman J: Tumor angiogenesis: A possible control point in tumor growth. Ann Intern Med 1975;82:96-100.
15. Thorpe PE, and Burrows FJ: Antibody-directed targeting of the vasculature of solid tumors. Breast Cancer Res Treat 1995;36(2):237-251.
16. Bogard WC, Jr, Dean RT, Deo Y, Fuchs R, Mattis JA, McLean AA, and Berger HJ: Practical considerations in the production, purification, and formulation of monoclonal antibodies for immunoscintigraphy and immunotherapy. Semin Nucl Med 1989;19:202-220.
17. Abrams PG, Ochs JJ, Giardina SL, Morgan AC, Wilburn SB, Wilt AR, Oldham RK, and Foon KA: Production of large quantities of human immunoglobulin in the ascites of athymic mice: Implications for the development of anti-human idiotype monoclonal antibodies. J Immunol 1984;132:1611-1613.
18. Dohlsten M, Lando PA, Bjork P, Abrahms'en L, Ohlsson L, Lind P, and Kalland T: Immunotherapy of human colon cancer by antibody-targeted superantigens. Cancer Immunol Immunother 1995;41:162-168.
19. Knutson VP, Buck RA, and Moreno RM: Purification of a murine monoclonal antibody of the IgM class [see comments]. J Immunol Meth 1991;136:151-157.
20. P'Eterfy F, Miholics E, and Boros B: Improved method for isolation of human IgM as a by-product. Ann Immunol Hung 1975;18:123-129.
21. Clezardin P, Hunter NR, MacGregor IR, MacGregor JL, Pepper DS, and Dawes J: Tandem purification of mouse IgM monoclonal antibodies produced in vitro using anion-exchange and gel fast protein liquid chromatography. J Chromatogr 1986;358:209-218.
22. Wichmann A, and Borg H: Purification of human immunoglobulin M by affinity chromatography on protamine-Sepharose. Biochim Biophys Acta 1977;490:363-369.
23. Kleine R, Klapperstuck M, Chukhrova AI, and Lapuk VA: Affinity chromatography of a myeloma immunoglobulin M and its tryptic Fab and (Fc)5 fragments using lectins covalently coupled to sepharose 4B. Mol Immunol 1979;16:421-425.
24. Merril CR, Goldman D, and Van KML: Gel protein stains: Silver stain. Meth Enzymol 1984;104:441-447.
25. Cormont F, Manouvriez P, De CL, and Bazin H: The use of rat monoclonal antibodies to characterize, quantify, and purify polyclonal or monoclonal mouse IgM. Meth Enzymol 1986;121: 622-631.
26. Venkateswaran S, Blanckaert V, and Schelling M: Production of anti-fibroblast growth factor receptor monoclonal antibodies by in vitro immunization. Hybridoma 1992;11:729-739.
27. Jaye M, Schlessinger J, and Dionne CA: Fibroblast growth factor receptor tyrosine kinases: Molecular analysis and signal transduction. Biochim Biophys Acta 1992;1135:185-199.
28. Venkateswaran S, Blanckaert V, and Schelling ME: Membrane fragments from cultured endothelial cells for use in screening anti-FGF receptor antibodies. J Tiss Cult Meth 1992;14(3):159-162.
29. Laemmli UK: Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970;227(259):680-685.
30. Merril CR, Dunau ML, and Goldman D: A rapid sensitive silver stain for polypeptides in polyacrylamide gels. Anal Biochem 1981;110(1):201-207.
31. Goding JW: Monoclonal antibodies: Principles and Practice. Academic Press, New York, 1986.
32. Gemski MJ, Doctor BP, Gentry MK, Pluskal MG, and Strickler MP: Single step purification of monoclonal antibody from murine ascites and tissue culture fluids by anion exchange high performance liquid chromatography. Biotechniques 1985;3:378-384.
33. Stephenson JR, Lee JM, and Wilton SPD: Production and purification of murine monoclonal antibodies: Aberrant elution from protein A-Sepharose 4B. Anal Biochem 1984;142(1):189-195.
34. Coppola G, Underwood J, Cartwright G, and Heam MT: High-performance liquid chromatography of amino acids, peptides and proteins. XCIII. Comparison of methods for the purification of mouse monoclonal immunoglobulin M autoantibodies. J Chromatogr 1989;476:269-290.
35. Cuatrecasas P: Agarose derivatives for purification of protein by affinity chromatography. Nature 1970;228:1327-1328.
36. Tan Wilson AL, Reichlin M, and Noble RW: Isolation and characterization of low and high affinity goat antibodies directed to single antigenic sites on human hemoglobin. Immunohistochemistry 1976;13(11):921-927.
37. Staak C, Salchow F, Clausen PH, and Luge E. Polystyrene as an affinity chromatography matrix for the purification of antibodies. J Immunol Meth 1996;194:141-146.
38. Tsang VC, and Wilkins PP: Optimum dissociating condition for immunoaffinity and preferential isolation of antibodies with high specific activity. J Immunol Meth 1991;138(2):291-299.
39. Karlsson GB, and Platt FM: Analysis and isolation of human transferrin receptor using the OKT-9 monoclonal antibody covalently crosslinked to magnetic beads. Anal Biochem 1991;199:219-222.
40. De R-MA, Zeijlemaker WP, Von DBAE, and Out TA: Evaluation of a method of production and purification of monoclonal antibodies for clinical applications. J Immunol Meth 1987;102 (2):187-193.